» Articles » PMID: 36481320

Mesenchymal Stem/stromal Cells from a Transplanted, Asymptomatic Patient with Fanconi Anemia Exhibit an Aging-like Phenotype and Dysregulated Expression of Genes Implicated in Hematopoiesis and Myelodysplasia

Overview
Journal Cytotherapy
Publisher Elsevier
Date 2022 Dec 8
PMID 36481320
Authors
Affiliations
Soon will be listed here.
Abstract

Background Aims: Fanconi anemia (FA) is an inherited bone marrow failure syndrome caused by defects in the repair of DNA inter-strand crosslinks and manifests as aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia. FA also causes defects in mesenchymal stromal cell (MSC) function, but how different FA gene mutations alter function remains understudied.

Methods: We compared the growth, differentiation and transcript profile of a single MSC isolate from an asymptomatic patient with FA with a FANCG nonsense mutation who underwent hematopoietic stem cell transplantation 10 years prior to that from a representative healthy donor (HD).

Results: We show that FANCG MSCs exhibit rapid onset of growth cessation, skewed bi-lineage differentiation in favor of adipogenesis and increased cellular oxidate stress consistent with an aging-like phenotype. Transcript profiling identified pathways related to cell growth, senescence, cellular stress responses and DNA replication/repair as over-represented in FANCG MSC, and real-time polymerase chain reaction confirmed these MSCs expressed reduced levels of transcripts implicated in cell growth (TWIST1, FGFR2v7-8) and osteogenesis (TWIST1, RUNX2) and increased levels of transcripts regulating adipogenesis (GPR116) and insulin signaling. They also expressed reduced levels of mRNAs implicated in HSC self-maintenance and homing (KITLG, HGF, GDNF, PGF, CFB, IL-1B and CSF1) and elevated levels of those implicated in myelodysplasia (IL-6, GDF15).

Conclusions: Together, these findings demonstrate how inactivation of FANCG impacts MSC behavior, which parallels observed defects in osteogenesis, HSC depletion and leukemic blast formation seen in patients with FA.

Citing Articles

The Evolving Landscape of Potency Assays.

Burns J Adv Exp Med Biol. 2023; 1420:165-189.

PMID: 37258790 DOI: 10.1007/978-3-031-30040-0_11.

References
1.
Shimamura A, Alter B . Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010; 24(3):101-22. PMC: 3733544. DOI: 10.1016/j.blre.2010.03.002. View

2.
Lecourt S, Vanneaux V, Leblanc T, Leroux G, Ternaux B, Benbunan M . Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients. Stem Cells Dev. 2009; 19(2):203-8. DOI: 10.1089/scd.2009.0062. View

3.
Boregowda S, Krishnappa V, Chambers J, LoGrasso P, Lai W, Ortiz L . Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells. 2012; 30(5):975-87. PMC: 3683654. DOI: 10.1002/stem.1069. View

4.
Zhai Y, Zhang J, Wang H, Lu W, Liu S, Yu Y . Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells. J Exp Clin Cancer Res. 2016; 35(1):147. PMC: 5029001. DOI: 10.1186/s13046-016-0405-0. View

5.
Franceschi R . The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med. 2000; 10(1):40-57. DOI: 10.1177/10454411990100010201. View